Teri L. Lawver

Teri L. Lawver

EVP, Chief Commercial OfficeratDexcom· In proxies 2023–2024

Pay in FY2024-1% from the year before · Dexcom stock -37.3% the same year

Teri L. Lawver was paid $6.5M in FY2024 (Dec), down 1%. Dexcom stock fell 37.3% that year.

Pay$100 in the stock at the end of FY22 → $69
Pay is from the Summary Compensation Table of each Dexcom proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. DexcomPublic company · 3 yr
    • EVP, Chief Commercial Officer2023 – Present · 3 yrStock in role -28%

Roles come from the proxy statements of each company.

Activity

No new filings about this person in the feed.

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?